FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine and can be used for treating mucoviscidosis in an individual suffering from P. aeruginosa pulmonary infection. That is ensured by administering an aerosol solution containing levofloxacin or ofloxacin in the concentration from approximately 50 mg/ml to approximately 200 mg/ml, and a bivalent or a trivalent cation in the concentration from approximately 50 mM to approximately 400 mM into the individual. That provides reducing expectoration P. aeruginosa density by min. 40%. There are also provided methods of treating mucoviscidosis and a method of reducing small airway resistance.
EFFECT: group of inventions enables reducing bronchial obstruction in the mucoviscidosis patients.
25 cl, 17 dwg, 32 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS OF TREATING PULMONARY BACTERIAL INFECTION WITH APPLICATION OF FLUOROQUINOLONES | 2010 |
|
RU2535056C2 |
| METHOD OF TREATING PULMONARY DISEASES WITH LIPOSOMAL AMIKACIN FORMULATIONS | 2009 |
|
RU2537238C2 |
| AEROSOLIZED FLUOROQUINOLONES AND USES THEREOF | 2006 |
|
RU2603638C2 |
| AEROSOL FLUOROCHINOLONES AND THEIR APPLICATIONS | 2006 |
|
RU2428986C2 |
| ALPHA-1 PROTEINASE INHIBITOR FOR DELAY OF BEGINNING OR PROGRESS OF PULMONARY EXACERBATIONS | 2012 |
|
RU2635482C2 |
| INTRAPULMONARY ADMINISTRATION OF FUOROQUINOLONE | 2009 |
|
RU2497524C2 |
| STABLE COMPOSITIONS OF ASCORBIC ACID AND METHODS OF THEIR USE | 2018 |
|
RU2799046C2 |
| CATIONS OF MONOVALENT METALS OF DRY POWDERS FOR INHALATIONS | 2011 |
|
RU2640921C2 |
| PEPTIDES AND USE THEREOF | 2011 |
|
RU2590706C2 |
| METHODS FOR DIAGNOSING AND TREATING RELATED TO TH2 INHIBITION | 2011 |
|
RU2578468C2 |
